Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Mar 2026 is 4.70% vs -2.40% in Mar 2025
Consolidate Net Profit
YoY Growth in quarter ended Mar 2026 is 83.07% vs 6,807.32% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Mar 2026 is 23.40% vs 11.92% in Mar 2025
Interest
YoY Growth in quarter ended Mar 2026 is -63.43% vs -16.82% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025
Compare Quarterly Results Of Santen Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is 10.94% vs 5.41% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 4.70% vs -2.40% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 90.99% vs 1.91% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 83.07% vs 6,807.32% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is 45.24% vs -0.91% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 23.40% vs 11.92% in Mar 2025
Quarterly - Interest
QoQ Growth in quarter ended Mar 2026 is 61.01% vs -23.37% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -63.43% vs -16.82% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025






